This is a table of type proper and their frequencies. Use it to search & browse the list to learn more about your study carrel.
| proper | frequency |
|---|---|
| SARS | 3281 |
| CoV-2 | 1560 |
| T | 1400 |
| COVID-19 | 1244 |
| B | 1171 |
| HIV | 1058 |
| RNA | 999 |
| United | 860 |
| Vaccine | 806 |
| Health | 802 |
| CoV | 795 |
| RSV | 771 |
| A | 766 |
| HA | 764 |
| States | 745 |
| DNA | 745 |
| S | 729 |
| Ebola | 700 |
| H5N1 | 650 |
| Fig | 640 |
| CD8 | 635 |
| HIV-1 | 627 |
| II | 592 |
| VLP | 587 |
| H1N1 | 559 |
| US | 549 |
| MVA | 547 |
| CD4 | 533 |
| China | 512 |
| IFN | 492 |
| MHC | 490 |
| mRNA | 489 |
| Influenza | 479 |
| C | 471 |
| Zika | 467 |
| MERS | 459 |
| IgA | 438 |
| M | 411 |
| World | 398 |
| Africa | 388 |
| Table | 378 |
| Immunization | 376 |
| FDA | 374 |
| • | 360 |
| PCR | 353 |
| Development | 335 |
| National | 331 |
| hepatitis | 321 |
| NDV | 318 |
| HPV | 313 |
| USA | 311 |
| Vaccines | 306 |
| BCG | 295 |
| WHO | 294 |
| Europe | 289 |
| IgG | 287 |
| Phase | 284 |
| RV | 281 |
| ELISA | 280 |
| India | 276 |
| Immunogenicity | 276 |
| HLA | 276 |
| Organization | 274 |
| Safety | 272 |
| F | 266 |
| Disease | 256 |
| UK | 254 |
| West | 253 |
| Institute | 250 |
| CpG | 244 |
| Newcastle | 240 |
| I | 238 |
| AIDS | 231 |
| N | 230 |
| Virus | 228 |
| sha | 225 |
| Asia | 224 |
| Research | 222 |
| MMR | 222 |
| DOI | 220 |
| CTL | 219 |
| ID | 218 |
| Committee | 218 |
| B. | 216 |
| nan | 215 |
| Human | 215 |
| Brazil | 214 |
| TB | 214 |
| HBV | 211 |
| Control | 206 |
| IPV | 204 |
| America | 204 |
| CDC | 203 |
| PLGA | 200 |
| E. | 198 |
| C. | 198 |
| Coronavirus | 196 |
| New | 191 |
| sera | 190 |
| S. | 189 |
| NPs | 187 |
| CMV | 186 |
| Group | 184 |
| Nile | 182 |
| University | 180 |
| H3N2 | 179 |
| EBOV | 177 |
| South | 177 |
| East | 176 |
| U.S. | 172 |
| Prevention | 172 |
| Evaluation | 171 |
| TLR | 170 |
| DCs | 166 |
| Ankara | 164 |
| Global | 164 |
| Efficacy | 164 |
| Animal | 162 |
| M. | 161 |
| Vaccination | 160 |
| Middle | 160 |
| III | 157 |
| DC | 157 |
| _ | 155 |
| Vero | 151 |
| Advisory | 150 |
| CoV-1 | 149 |
| vivo | 148 |
| ACE2 | 147 |
| RT | 144 |
| MLV | 143 |
| Japan | 143 |
| International | 142 |
| Hong | 141 |
| NP | 139 |
| Mycobacterium | 137 |
| Escherichia | 136 |
| MS | 136 |
| Mucosal | 135 |
| AS03 | 135 |
| Protection | 134 |
| Drug | 134 |
| Diseases | 133 |
| Hib | 132 |
| J | 132 |
| MF59 | 131 |
| Act | 131 |
| mg | 128 |
| D | 128 |
| ND | 127 |
| Canada | 127 |
| CEPI | 127 |
| Hepatitis | 126 |
| Pasteur | 126 |
| γ | 125 |
| S1 | 124 |
| Department | 124 |
| Plasmodium | 124 |
| IM | 123 |
| L. | 122 |
| Study | 121 |
| baculovirus | 120 |
| Induction | 120 |
| European | 120 |
| Australia | 120 |
| AS01 | 120 |
| M2 | 119 |
| CAF01 | 119 |
| Infectious | 118 |
| Administration | 117 |
| Salmonella | 116 |
| Kong | 116 |
| E | 115 |
| antigen | 115 |
| G | 114 |
| IgM | 112 |
| IL-6 | 112 |
| QS-21 | 111 |
| PRRSV | 111 |
| Public | 110 |
| RBD | 109 |
| North | 109 |
| HI | 109 |
| TGEV | 108 |
| PIKA | 108 |
| Germany | 108 |
| parainfluenza | 107 |
| EV71 | 107 |
| Immune | 104 |
| Center | 104 |
| LATAM | 104 |
| uenza | 104 |
| HCV | 103 |
| H7N9 | 103 |
| Valley | 103 |
| SIV | 103 |
| TLR4 | 103 |
| Use | 102 |
| NK | 102 |
| Lyme | 101 |
| Food | 101 |
| Clinical | 101 |
| Protein | 100 |
| France | 100 |
| BALB | 100 |
| Rift | 99 |
| Novel | 99 |
| Figure | 99 |
| Medical | 97 |
| Kingdom | 97 |
| Shigella | 97 |
| Medicine | 96 |
| OPV | 96 |
| IBV | 95 |
| ZIKV | 94 |
| Wuhan | 94 |
| LT | 94 |
| HTL | 94 |
| American | 94 |
| Centers | 93 |
| EB1 | 93 |
| P. | 93 |
| VP1 | 92 |
| RTS | 92 |
| HBsAg | 92 |
| Chitosan | 92 |
| Bordetella | 92 |
| Association | 92 |
| CDV | 91 |
| N. | 91 |
| PBS | 91 |
| Veterinary | 91 |
| Gag | 90 |
| Thailand | 88 |
| Russia | 88 |
| Adjuvant | 88 |
| October | 87 |
| England | 87 |
| Practices | 86 |
| NIH | 86 |
| IL-12 | 86 |
| TNF | 85 |
| Pandemic | 85 |
| May | 85 |
| Dr. | 83 |
| GM | 82 |
| CT | 82 |
| FeLV | 82 |
| LAIV | 82 |
| VGG | 82 |
| fl | 80 |
| Protollin | 80 |
| Merck | 80 |
| Bac | 80 |
| September | 79 |
| April | 78 |
| H5 | 78 |
| System | 78 |
| VACV | 78 |
| OspA | 77 |
| MPL | 77 |
| IL-4 | 77 |
| DENV | 77 |
| ChAdOx1 | 77 |
| CSF | 77 |
| IV | 76 |
| Neisseria | 76 |
| State | 76 |
| Viral | 76 |
| haemagglutinin | 75 |
| Review | 75 |
| Env | 75 |
| Antibody | 75 |
| herpes | 74 |
| Recombinant | 74 |
| PEDV | 74 |
| K | 74 |
| ISCOM | 74 |
| Dengue | 74 |
| Delivery | 74 |
| Italy | 73 |
| ACIP | 73 |
| FIP | 73 |
| GMP | 73 |
| Measles | 73 |
| Mexico | 73 |
| Toll | 73 |
| nucleoprotein | 73 |
| ADE | 72 |
| Antigen | 72 |
| FMDV | 72 |
| GAVI | 72 |
| GBS | 72 |
| IL-2 | 72 |
| L1 | 72 |
| Lassa | 72 |
| S2 | 72 |
| Science | 72 |
| ebola | 72 |
| α | 72 |
| Streptococcus | 71 |
| Respiratory | 71 |
| H | 71 |
| Agency | 70 |
| NIAID | 70 |
| J. | 70 |
| VSV | 70 |
| PDVAC | 70 |
| ® | 70 |
| TM | 70 |
| WNV | 69 |
| Program | 69 |
| PS | 69 |
| Leishmania | 69 |
| Calmette | 69 |
| L | 68 |
| IL-18 | 68 |
| Inc. | 68 |
| York | 68 |
| Nipah | 68 |
| UNICEF | 68 |
| pH | 68 |
| IL-10 | 67 |
| Adenovirus | 67 |
| Effectiveness | 67 |
| HAI | 67 |
| Nanoparticle | 67 |
| LPS | 67 |
| PRF | 67 |
| Syndrome | 67 |
| gp120 | 67 |
| TLRs | 66 |
| Services | 66 |
| March | 66 |
| GP | 66 |
| December | 66 |
| Biological | 66 |
| Report | 65 |
| Molecular | 65 |
| Intranasal | 65 |
| Republic | 64 |
| Analysis | 64 |
| CAV | 64 |
| June | 64 |
| poxvirus | 64 |
| TLR3 | 64 |
| Supplementary | 64 |
| endosomal | 63 |
| Rabies | 63 |
| Norwalk | 63 |
| Marburg | 63 |
| M1 | 63 |
| Korea | 63 |
| I. | 63 |
| H. | 63 |
| Gavi | 63 |
| EPI | 63 |
| CBER | 63 |
| Brucella | 63 |
| Laboratory | 63 |
| TCID | 62 |
| IgE | 62 |
| infl | 62 |
| intranasal | 61 |
| VAERS | 61 |
| PT | 61 |
| Lister | 61 |
| IEDB | 60 |
| Cell | 60 |
| CMI | 60 |
| Identification | 60 |
| gE | 60 |
| i.m | 59 |
| effi | 59 |
| ODN | 59 |
| MD | 59 |
| LC16m8 | 59 |
| Fc | 59 |
| Biologics | 59 |
| E2 | 58 |
| Guillain | 58 |
| Freund | 58 |
| Netherlands | 58 |
| Indonesia | 58 |
| Plant | 58 |
| disease | 58 |
| heterologous | 57 |
| R. | 57 |
| Peptide | 57 |
| Jenner | 57 |
| Haemophilus | 57 |
| H7 | 57 |
| A. | 57 |
| FMD | 56 |
| Adults | 56 |
| Americas | 56 |
| FCoV | 56 |
| Union | 56 |
| Healthy | 56 |
| MV | 56 |
| Systems | 56 |
| Assessment | 55 |
| APC | 55 |
| TLR2 | 55 |
| BEVS | 55 |
| FIV | 55 |
| ovo | 54 |
| amantadine | 54 |
| V | 54 |
| Network | 54 |
| Leishmune | 54 |
| Institutes | 54 |
| HSV | 54 |
| EU | 54 |
| Chlamydia | 54 |
| Bacillus | 54 |
| FPV | 53 |
| August | 53 |
| Commons | 53 |
| Creative | 53 |
| Oxford | 53 |
| H7N7 | 53 |
| Sciences | 53 |
| Singapore | 53 |
| WSAVA | 53 |
| fi | 52 |
| bronchiseptica | 52 |
| NF | 52 |
| Latin | 52 |
| GC | 52 |
| CC | 52 |
| Ministry | 51 |
| Academy | 51 |
| Gene | 51 |
| July | 51 |
| HN | 51 |
| Programme | 51 |
| Sabin | 51 |
| benthamiana | 51 |
| Sanofi | 51 |
| VaxiJen | 51 |
| Centre | 50 |
| D. | 50 |
| Effect | 50 |
| January | 50 |
| Malaysia | 50 |
| Office | 50 |
| Rapid | 50 |
| influenza | 50 |
| meta | 50 |
| virus | 50 |
| CVB3-VLP | 49 |
| February | 49 |
| Guidance | 49 |
| K. | 49 |
| Infection | 49 |
| IgG2a | 49 |
| Philippines | 49 |
| simplex | 49 |
| zanamivir | 49 |
| TDV | 49 |
| anti | 49 |
| GlaxoSmithKline | 48 |
| nan | 48 |
| Aedes | 48 |
| Baculovirus | 48 |
| Foundation | 48 |
| Feline | 48 |
| RMSD | 48 |
| Rotavirus | 48 |
| Structure | 48 |
| Western | 48 |
| Working | 48 |
| CYD | 47 |
| Ad26 | 47 |
| Allergy | 47 |
| Alum | 47 |
| Alzheimer | 47 |
| Argentina | 47 |
| Preparedness | 47 |
| Cross | 47 |
| Immunity | 47 |
| Plasmid | 47 |
| Ramachandran | 47 |
| Y | 47 |
| YF | 47 |
| PDB | 46 |
| Alliance | 46 |
| Borrelia | 46 |
| IL-1 | 46 |
| Li | 46 |
| H9N2 | 46 |
| Smith | 46 |
| doc_id | 46 |
| Studies | 46 |
| poly | 46 |
| Impact | 46 |
| Trial | 46 |
| Tn | 46 |
| Initiative | 45 |
| ALVAC | 45 |
| Americans | 45 |
| DDA | 45 |
| Hemisphere | 45 |
| GCRV | 45 |
| Kim | 45 |
| Mycoplasma | 45 |
| SVCV | 45 |
| School | 45 |
| bp | 45 |
| oseltamivir | 45 |
| Guidelines | 44 |
| AS03-adjuvanted | 44 |
| California | 44 |
| Children | 44 |
| DU | 44 |
| EMA | 44 |
| Flu | 44 |
| PR8 | 44 |
| LNP | 44 |
| MARV | 44 |
| ORF | 44 |
| Practice | 44 |
| Vietnam | 44 |
| rAd | 44 |
| IgG1 | 43 |
| Agriculture | 43 |
| Assembly | 43 |
| DTP | 43 |
| Epidemic | 43 |
| FCV | 43 |
| HCS | 43 |
| Northern | 43 |
| Polio | 43 |
| Products | 43 |
| Taiwan | 43 |
| USDA | 43 |
| VZV | 43 |
| PIV | 43 |
| LaSota | 42 |
| Application | 42 |
| Central | 42 |
| CoV. | 42 |
| Dryvax | 42 |
| Hendra | 42 |
| Medicines | 42 |
| Serum | 42 |
| Social | 42 |
| Southeast | 42 |
| monophosphoryl | 42 |
| β | 42 |
| PEI | 41 |
| Appendix | 41 |
| BHV-1 | 41 |
| Council | 41 |
| DCVMN | 41 |
| Epidemiology | 41 |
| Guinea | 41 |
| Liu | 41 |
| November | 41 |
| Technology | 41 |
| People | 41 |
| R | 41 |
| SV40 | 41 |
| calicivirus | 41 |
| inflammasome | 41 |
| meningitidis | 41 |
| Progress | 41 |
| van | 41 |
| Congo | 40 |
| G. | 40 |
| Design | 40 |
| Data | 40 |
| BY | 40 |
| Chen | 40 |
| CI | 40 |
| HADDOCK | 40 |
| GSK | 40 |
| der | 40 |
| Hospital | 40 |
| Immunology | 40 |
| NSP1 | 40 |
| Peyer | 40 |
| Staphylococcus | 40 |
| Surveillance | 40 |
| TLR7 | 40 |
| Th2 | 40 |
| specifi | 40 |
| Ad5 | 39 |
| BRD | 39 |
| Epitope | 39 |
| IC | 39 |
| JE | 39 |
| Mumps | 39 |
| Project | 39 |
| Vaccinia | 39 |
| Yersinia | 39 |
| Zaire | 39 |
| i.d | 39 |
| measles | 39 |
| microneedle | 39 |
| NALT | 38 |
| Biotechnology | 38 |
| EID | 38 |
| EM | 38 |
| EVD | 38 |
| Emergency | 38 |
| Finland | 38 |
| H2N2 | 38 |
| SPF | 38 |
| OC43 | 38 |
| | | 38 |
| Saif | 38 |
| TGF | 38 |
| administration | 38 |
| inovirus | 38 |
| Risk | 38 |
| CoVs | 37 |
| Action | 37 |
| Arabia | 37 |
| Biotech | 37 |
| CNS | 37 |
| CPV2 | 37 |
| ER | 37 |
| Laboratories | 37 |
| MEPVC | 37 |
| Moderna | 37 |
| NHP | 37 |
| Smallpox | 37 |
| ZEBOV | 37 |
| protein | 37 |
| Nations | 36 |
| Day | 36 |
| EWS | 36 |
| Enhancement | 36 |
| GMT | 36 |
| General | 36 |
| M2e | 36 |
| Matrix | 36 |
| GISRS | 36 |
| Nicotiana | 36 |
| PIV3 | 36 |
| PLA | 36 |
| nanovaccine | 36 |
| Response | 36 |
| Saudi | 36 |
| X | 36 |
| OVA | 36 |
| FML | 35 |
| Humoral | 35 |
| Gold | 35 |
| Federal | 35 |
| Care | 35 |
| Discovery | 35 |
| Class | 35 |
| Chikungunya | 35 |
| BLA | 35 |
| Information | 35 |
| Louis | 35 |
| M13 | 35 |
| Wu | 35 |
| Pfizer | 35 |
| nucleocapsid | 35 |
| koi | 35 |
| haemolytica | 35 |
| panleukopenia | 35 |
| WTP | 35 |
| TT | 35 |
| Sweden | 35 |
| Plan | 35 |
| H1 | 34 |
| Ag | 34 |
| Cationic | 34 |
| CoV2 | 34 |
| Coalition | 34 |
| DRB1 | 34 |
| FluMist | 34 |
| Geneva | 34 |
| Guérin | 34 |
| BRSV | 34 |
| Healthcare | 34 |
| Service | 34 |
| Wang | 34 |
| medRxiv | 34 |
| Survey | 34 |
| Ig | 34 |
| Q | 34 |
| NCBI | 34 |
| Lancet | 34 |
| Nigeria | 34 |
| NYVAC | 33 |
| CD | 33 |
| Epstein | 33 |
| Fever | 33 |
| Guerin | 33 |
| IBDV | 33 |
| Immunoinformatics | 33 |
| Infections | 33 |
| LC16mO | 33 |
| Leptospira | 33 |
| Model | 33 |
| MDA | 33 |
| pandemic | 33 |
| i.n | 33 |
| þ | 33 |
| Synthesis | 33 |
| n.a | 33 |
| kg | 33 |
| immunostimulatory | 33 |
| Production | 33 |
| Y. | 33 |
| Van | 33 |
| V. | 33 |
| Universal | 33 |
| T. | 33 |
| 8) | 32 |
| Access | 32 |
| Al | 32 |
| Collins | 32 |
| De | 32 |
| Good | 32 |
| Herpes | 32 |
| IU | 32 |
| Intradermal | 32 |
| P1 | 32 |
| PEG | 32 |
| Spain | 32 |
| TLR9 | 32 |
| Th1 | 32 |
| VEE | 32 |
| mAbs | 32 |
| zoster | 32 |
| Regulatory | 32 |
| Expert | 31 |
| Gates | 31 |
| GFP | 31 |
| Fund | 31 |
| CTB | 31 |
| Commission | 31 |
| Candidate | 31 |
| Mechanisms | 31 |
| CPV | 31 |
| John | 31 |
| Helicobacter | 31 |
| MuV | 31 |
| Pediatric | 31 |
| Switzerland | 31 |
| Th | 31 |
| Vibrio | 31 |
| Viruses | 31 |
| ed | 31 |
| gB | 31 |
| microneedles | 31 |
| monocyte | 31 |
| NL63 | 31 |
| EUA | 30 |
| Koch | 30 |
| Immunol | 30 |
| HRV | 30 |
| FHA | 30 |
| Malaria | 30 |
| Collaboration | 30 |
| CTP | 30 |
| Based | 30 |
| Ab | 30 |
| AAV | 30 |
| Lkt | 30 |
| OIE | 30 |
| PCV7 | 30 |
| Swine | 30 |
| virosomes | 30 |
| ciency | 30 |
| aP | 30 |
| Type | 30 |
| TLR-3 | 30 |
| immunodefi | 30 |
| Sinovac | 30 |
| Phage | 30 |
| Pathogenesis | 30 |
| PRRs | 30 |
| Robert | 30 |
| BoHV-1 | 29 |
| City | 29 |
| Cells | 29 |
| CTLs | 29 |
| CSFV | 29 |
| Abstract | 29 |
| Barré | 29 |
| Bank | 29 |
| ASIA | 29 |
| AS04 | 29 |
| IL-15 | 29 |
| Genome | 29 |
| High | 29 |
| herpesvirus-1 | 29 |
| PA | 29 |
| Plotkin | 29 |
| TMPRSS2 | 29 |
| Treatment | 29 |
| UTR | 29 |
| VLPs | 29 |
| Zhang | 29 |
| remdesivir | 29 |
| serovar | 29 |
| siRNA | 29 |
| Nanoparticles | 29 |
| Ltd. | 28 |
| HCoV | 28 |
| ILTV | 28 |
| Nature | 28 |
| MDCK | 28 |
| E3 | 28 |
| Eimeria | 28 |
| A(H1N1)pdm09 | 28 |
| Comparative | 28 |
| Box | 28 |
| Barre | 28 |
| BV | 28 |
| BTV | 28 |
| ADEM | 28 |
| NP+M1 | 28 |
| Trials | 28 |
| OppA | 28 |
| TLR5 | 28 |
| east | 28 |
| cytomegalovirus | 28 |
| Prediction | 28 |
| White | 28 |
| Virology | 28 |
| Zealand | 28 |
| T7 | 28 |
| Southern | 28 |
| Rule | 28 |
| RTBV | 28 |
| RNAse | 28 |
| serogroup | 28 |
| IRF3 | 27 |
| Covid-19 | 27 |
| IIa | 27 |
| HPAIV | 27 |
| Government | 27 |
| Force | 27 |
| Epitopes | 27 |
| Ebolavirus | 27 |
| DR | 27 |
| SC | 27 |
| Coronaviruses | 27 |
| ClusPro | 27 |
| Cancer | 27 |
| CRM | 27 |
| CD40 | 27 |
| Brighton | 27 |
| Barr | 27 |
| African | 27 |
| < | 27 |
| Johnson | 27 |
| Innovation | 27 |
| TASSER | 27 |
| Kumar | 27 |
| Strategies | 27 |
| LC | 27 |
| reovirus | 27 |
| enterotoxigenic | 27 |
| Texas | 27 |
| TCR | 27 |
| σ | 27 |
| T4 | 27 |
| Subbarao | 27 |
| kb | 27 |
| Small | 27 |
| Reporting | 27 |
| Poly | 27 |
| PLG | 27 |
| PAHO | 27 |
| OH | 27 |
| London | 27 |
| SAM | 27 |
| Challenge | 26 |
| Giardia | 26 |
| Generation | 26 |
| Front | 26 |
| Cov-2 | 26 |
| Chap | 26 |
| Bill | 26 |
| CVL | 26 |
| COVID | 26 |
| Blueprint | 26 |
| Basel | 26 |
| Associated | 26 |
| Anti | 26 |
| Immunisation | 26 |
| IIV | 26 |
| Recommendations | 26 |
| Immunotherapy | 26 |
| Tdap | 26 |
| trans | 26 |
| rabies | 26 |
| Indian | 26 |
| kappaB | 26 |
| gD | 26 |
| War | 26 |
| purifi | 26 |
| Strategy | 26 |
| Spike | 26 |
| Scientific | 26 |
| Rappuoli | 26 |
| Pandemrix | 26 |
| KHV | 26 |
| H3 | 25 |
| Emerging | 25 |
| EP | 25 |
| COVID19 | 25 |
| Director | 25 |
| Delhi | 25 |
| Coronaviridae | 25 |
| Congress | 25 |
| CRS | 25 |
| IND | 25 |
| CFR | 25 |
| Board | 25 |
| BVDV | 25 |
| Attribution | 25 |
| AllerTOP | 25 |
| AI | 25 |
| A2 | 25 |
| 3D | 25 |
| HPIV | 25 |
| VP4 | 25 |
| Listeria | 25 |
| Salk | 25 |
| Med | 25 |
| mRNA-1273 | 25 |
| heterotypic | 25 |
| Th17 | 25 |
| TPP | 25 |
| TIV | 25 |
| Sci | 25 |
| WSSV | 25 |
| SE | 25 |
| RVFV | 25 |
| Paul | 25 |
| Pan | 25 |
| P | 25 |
| Nabs | 25 |
| NC | 25 |
| Regional | 25 |
| HKU1 | 24 |
| Edward | 24 |
| Expanded | 24 |
| GI | 24 |
| Globo | 24 |
| Gupta | 24 |
| Langerhans | 24 |
| HPAI | 24 |
| JEV | 24 |
| Journal | 24 |
| Lee | 24 |
| DPT | 24 |
| EV | 24 |
| BSA | 24 |
| Comparison | 24 |
| Community | 24 |
| Codon | 24 |
| Childhood | 24 |
| CRISPR | 24 |
| CD80 | 24 |
| Biologicals | 24 |
| Bell | 24 |
| Manufacturing | 24 |
| Army | 24 |
| Ad | 24 |
| AMR | 24 |
| MF59-adjuvanted | 24 |
| CHIKV | 24 |
| Marek | 24 |
| Sera | 24 |
| Mass | 24 |
| sars | 24 |
| s.c | 24 |
| kDa | 24 |
| eff | 24 |
| adenoviral | 24 |
| VP2 | 24 |
| von | 24 |
| Transmission | 24 |
| Task | 24 |
| TDB | 24 |
| Society | 24 |
| VSD | 24 |
| Sect | 24 |
| Melinda | 24 |
| SH | 24 |
| Miller | 24 |
| Moss | 24 |
| NITAG | 24 |
| Nobel | 24 |
| Mtb | 24 |
| Novavax | 24 |
| Organisation | 24 |
| Pradesh | 24 |
| Pseudomonas | 24 |
| Russian | 24 |
| Corporation | 23 |
| GPGPG | 23 |
| Engineering | 23 |
| EAAAK | 23 |
| E6 | 23 |
| Dis | 23 |
| Cuba | 23 |
| Au | 23 |
| CVB3-VLPs | 23 |
| CTV | 23 |
| CP | 23 |
| CAI | 23 |
| BC | 23 |
| Advax | 23 |
| AS02 | 23 |
| IAV | 23 |
| HPLC | 23 |
| Innovations | 23 |
| ISCOMATRIX | 23 |
| VPD | 23 |
| Microbiology | 23 |
| type | 23 |
| ts | 23 |
| gp160 | 23 |
| cacy | 23 |
| association | 23 |
| novo | 23 |
| Technologies | 23 |
| Self | 23 |
| Rice | 23 |
| Region | 23 |
| Panel | 23 |
| Subunit | 23 |
| PCV2 | 23 |
| IL-5 | 22 |
| Life | 22 |
| GenBank | 22 |
| Hum | 22 |
| IFA | 22 |
| Inovio | 22 |
| Index | 22 |
| Ireland | 22 |
| Leone | 22 |
| Federation | 22 |
| Framework | 22 |
| Biomedical | 22 |
| FW | 22 |
| Division | 22 |
| Detection | 22 |
| Democratic | 22 |
| Cyprinus | 22 |
| Colombia | 22 |
| Chinese | 22 |
| Bio | 22 |
| BVD | 22 |
| Arntzen | 22 |
| A1 | 22 |
| License | 22 |
| GP64 | 22 |
| MEK | 22 |
| VV | 22 |
| Microneedle | 22 |
| trimeric | 22 |
| qPCR | 22 |
| mL | 22 |
| lg | 22 |
| aids | 22 |
| adjuvant | 22 |
| Wright | 22 |
| Webster | 22 |
| Vector | 22 |
| rst | 22 |
| URT | 22 |
| Protective | 22 |
| Thomas | 22 |
| NS | 22 |
| Novartis | 22 |
| Product | 22 |
| NiV | 22 |
| Quil | 22 |
| Regulations | 22 |
| Reverse | 22 |
| Th1-type | 22 |
| MPLA | 21 |
| Compendium | 21 |
| Great | 21 |
| Graham | 21 |
| GE | 21 |
| GA | 21 |
| FHV | 21 |
| Expression | 21 |
| EEC | 21 |
| Cytomegalovirus | 21 |
| Bangladesh | 21 |
| CD86 | 21 |
| CA | 21 |
| Butantan | 21 |
| Bovine | 21 |
| Bacille | 21 |
| BCR | 21 |
| Approach | 21 |
| Amantadine | 21 |
| NV | 21 |
| NS2 | 21 |
| Murphy | 21 |
| PRP | 21 |
| TBE | 21 |
| gp41 | 21 |
| Pacific | 21 |
| flavivirus | 21 |
| antigen(s | 21 |
| alphavirus | 21 |
| ZVL | 21 |
| VSVG | 21 |
| V3 | 21 |
| Technical | 21 |
| TSV | 21 |
| Yu | 21 |
| Springer | 21 |
| Sendai | 21 |
| SP | 21 |
| Rotarix | 21 |
| RhoA | 21 |
| Randomized | 21 |
| QS21 | 21 |
| Sierra | 21 |
| Pakistan | 21 |
| Green | 20 |
| FECV | 20 |
| FHV1 | 20 |
| GALT | 20 |
| Gardasil | 20 |
| Liberia | 20 |
| HPIV3 | 20 |
| HHS | 20 |
| HMPV | 20 |
| IL-17 | 20 |
| K12 | 20 |
| David | 20 |
| ETEC | 20 |
| Anopheles | 20 |
| Cytotoxic | 20 |
| College | 20 |
| Cervarix | 20 |
| Bm86 | 20 |
| Belshe | 20 |
| Belgium | 20 |
| Beijing | 20 |
| Balb | 20 |
| Applications | 20 |
| Advanced | 20 |
| ARDS | 20 |
| AOM | 20 |
| MDA5 | 20 |
| Lipid | 20 |
| Yang | 20 |
| MN | 20 |
| TMC | 20 |
| Management | 20 |
| interferon | 20 |
| flagellin | 20 |
| begomovirus | 20 |
| antibody | 20 |
| aa | 20 |
| Zanamivir | 20 |
| Vaccinomics | 20 |
| VHSV | 20 |
| Therapy | 20 |
| Th2-type | 20 |
| TMV | 20 |
| metapneumovirus | 20 |
| Summary | 20 |
| Pharmaceuticals | 20 |
| Sudan | 20 |
| One | 20 |
| PHS | 20 |
| PRR | 20 |
| Pediatrics | 20 |
| Mechanism | 20 |
| Policy | 20 |
| SUDV | 20 |
| Saharan | 20 |
| Prize | 20 |
| Secretary | 20 |
| Mann | 19 |
| IL-8 | 19 |
| Jones | 19 |
| LRTI | 19 |
| Likert | 19 |
| Mason | 19 |
| Martin | 19 |
| Meeting | 19 |
| PKR | 19 |
| PRN | 19 |
| HSP70 | 19 |
| HZ | 19 |
| EC | 19 |
| HDCS | 19 |
| French | 19 |
| Egypt | 19 |
| Edmonston | 19 |
| ERK | 19 |
| EHV-1 | 19 |
| E7 | 19 |
| Dose | 19 |
| Chile | 19 |
| BARDA | 19 |
| AstraZeneca | 19 |
| Pharmaceutical | 19 |
| Pasteurella | 19 |
| Times | 19 |
| Post | 19 |
| serologic | 19 |
| RA | 19 |
| ovalbumin | 19 |
| oligodeoxynucleotides | 19 |
| mosaic | 19 |
| enterotoxin | 19 |
| agalactiae | 19 |
| Zhao | 19 |
| Wyeth | 19 |
| Vet | 19 |
| U | 19 |
| Trust | 19 |
| middle | 19 |
| Text | 19 |
| Serologic | 19 |
| Testing | 19 |
| RMSF | 19 |
| Res | 19 |
| Seasonal | 19 |
| STI | 19 |
| Shiga | 19 |
| Stanley | 19 |
| Syncytial | 19 |
| Tang | 19 |
| Event | 18 |
| GVAP | 18 |
| FAO | 18 |
| First | 18 |
| Fisher | 18 |
| Fort | 18 |
| GIP | 18 |
| GTPV | 18 |
| ILI | 18 |
| Golgi | 18 |
| HepB | 18 |
| Hydroxychloroquine | 18 |
| ICU | 18 |
| KAg | 18 |
| KLH | 18 |
| Economic | 18 |
| Enhanced | 18 |
| Antibodies | 18 |
| Clin | 18 |
| Chadox1 | 18 |
| AAY | 18 |
| ASC | 18 |
| Adult | 18 |
| Alaska | 18 |
| Langmuir | 18 |
| Asian | 18 |
| BN | 18 |
| Bacteriophage | 18 |
| Brown | 18 |
| Burden | 18 |
| C57BL/6 | 18 |
| CAV-1 | 18 |
| CEF | 18 |
| CFA | 18 |
| CS | 18 |
| L2 | 18 |
| Hayden | 18 |
| Medicago | 18 |
| immunosenescence | 18 |
| W. | 18 |
| Yellow | 18 |
| allantoic | 18 |
| author(s | 18 |
| coxsackievirus | 18 |
| defi | 18 |
| herpesvirus | 18 |
| linear | 18 |
| VP3 | 18 |
| mousepox | 18 |
| nAbs | 18 |
| nef | 18 |
| ± | 18 |
| ¼ | 18 |
| � | 18 |
| NFκB | 18 |
| Vaccinology | 18 |
| immunoprophylaxis | 18 |
| Uganda | 18 |
| Preclinical | 18 |
| Tuberculosis | 18 |
| Norway | 18 |
| OD | 18 |
| OMP | 18 |
| Optimization | 18 |
| PAGE | 18 |
| Poland | 18 |
| Neuraminidase | 18 |
| RNP | 18 |
| RTSV | 18 |
| SPPV | 18 |
| Schistosoma | 18 |
| Tregs | 18 |
| R&D | 18 |
| Filamentous | 17 |
| MAGE | 17 |
| Forest | 17 |
| GalaxyRefine | 17 |
| H9 | 17 |
| HFRS | 17 |
| Huang | 17 |
| Israel | 17 |
| LD | 17 |
| La | 17 |
| NIBSC | 17 |
| MAPK | 17 |
| MVA85A | 17 |
| NLRP3 | 17 |
| NY | 17 |
| Nano | 17 |
| O | 17 |
| ORFs | 17 |
| Ontario | 17 |
| Flublok | 17 |
| Adjuvants | 17 |
| Family | 17 |
| FD&C | 17 |
| Park | 17 |
| Activation | 17 |
| Andhra | 17 |
| B19 | 17 |
| Biology | 17 |
| CSP | 17 |
| CVA16 | 17 |
| CVB | 17 |
| CVI-78 | 17 |
| Conference | 17 |
| Daily | 17 |
| Database | 17 |
| Dendritic | 17 |
| Dengvaxia | 17 |
| Draft | 17 |
| Electroporation | 17 |
| Ethics | 17 |
| PSORT | 17 |
| NAbs | 17 |
| Peru | 17 |
| caspase-1 | 17 |
| Taylor | 17 |
| Tetanus | 17 |
| Tolerability | 17 |
| TriMix | 17 |
| UN | 17 |
| VI | 17 |
| Vesicular | 17 |
| Washington | 17 |
| coccidiosis | 17 |
| TLR-4 | 17 |
| dendrimer | 17 |
| doi | 17 |
| fox | 17 |
| gamma | 17 |
| hexon | 17 |
| kB | 17 |
| rVSV | 17 |
| saponaria | 17 |
| Tat | 17 |
| plasmacytoid | 17 |
| TF | 17 |
| κB | 17 |
| TC-83 | 17 |
| ProSA | 17 |
| Professor | 17 |
| Province | 17 |
| RHDV | 17 |
| RVG | 17 |
| Reed | 17 |
| Remdesivir | 17 |
| Population | 17 |
| SAGE | 17 |
| SDS | 17 |
| SHIV | 17 |
| SPR | 17 |
| Scott | 17 |
| Soviet | 17 |
| Surface | 17 |
| SCR | 17 |
| Synthetic | 17 |
| HFMD | 16 |
| Forum | 16 |
| G1 | 16 |
| Georgia | 16 |
| Guangdong | 16 |
| Guardian | 16 |
| H2 | 16 |
| JL | 16 |
| Inflexal | 16 |
| Isolation | 16 |
| Eradication | 16 |
| James | 16 |
| Ltd | 16 |
| MAVS | 16 |
| MP-12 | 16 |
| MSD | 16 |
| F1-V | 16 |
| Cox | 16 |
| Enders | 16 |
| Denmark | 16 |
| Mayr | 16 |
| 35S | 16 |
| A/ | 16 |
| Adverse | 16 |
| Ann | 16 |
| Aujeszky | 16 |
| BP | 16 |
| Borreliella | 16 |
| British | 16 |
| Canine | 16 |
| Cellular | 16 |
| Cold | 16 |
| Company | 16 |
| DPP4 | 16 |
| Defense | 16 |
| CPE | 16 |
| Ma | 16 |
| Merial | 16 |
| Tomato | 16 |
| VN | 16 |
| Z | 16 |
| delta | 16 |
| epitopes | 16 |
| kJ | 16 |
| key | 16 |
| modifi | 16 |
| rAd5-S | 16 |
| ritonavir | 16 |
| sporozoite | 16 |
| tungro | 16 |
| vaccine | 16 |
| − | 16 |
| ≤ | 16 |
| Montanide | 16 |
| Treg | 16 |
| multicentre | 16 |
| Taenia | 16 |
| Publisher | 16 |
| NRAs | 16 |
| Speed | 16 |
| Non | 16 |
| Oseltamivir | 16 |
| Outbreak | 16 |
| Physicians | 16 |
| Platform | 16 |
| PE | 16 |
| Raf | 16 |
| Replication | 16 |
| Routine | 16 |
| SLE | 16 |
| RNAi | 16 |
| Sigma | 16 |
| Sindbis | 16 |
| F. | 15 |
| Flower | 15 |
| HVR2 | 15 |
| George | 15 |
| Garcia | 15 |
| File | 15 |
| Filo | 15 |
| Far | 15 |
| House | 15 |
| Hemagglutinin | 15 |
| Joint | 15 |
| IHNV | 15 |
| INO-4800 | 15 |
| IRF7 | 15 |
| IVE | 15 |
| Institut | 15 |
| Investigation | 15 |
| Lynn | 15 |
| M72 | 15 |
| Delta | 15 |
| EBV | 15 |
| Alexander | 15 |
| Davis | 15 |
| DTaP | 15 |
| MRC | 15 |
| A3 | 15 |
| ATP | 15 |
| Age | 15 |
| Atlanta | 15 |
| Avian | 15 |
| BSL3 | 15 |
| Bayesian | 15 |
| CD3 | 15 |
| CPS | 15 |
| CVB3 | 15 |
| Cap | 15 |
| Charles | 15 |
| ClinicalTrials.gov | 15 |
| Communication | 15 |
| Countries | 15 |
| Coxsackievirus | 15 |
| Ctenopharyngodon | 15 |
| DT | 15 |
| MMWR | 15 |
| Flaviviridae | 15 |
| Massachusetts | 15 |
| ammatory | 15 |
| Special | 15 |
| Tfh | 15 |
| Thermo | 15 |
| Third | 15 |
| VFC | 15 |
| Ward | 15 |
| Warp | 15 |
| Whitney | 15 |
| Williams | 15 |
| benefi | 15 |
| SCID | 15 |
| enterica | 15 |
| meningococcus | 15 |
| motifs | 15 |
| mucoadhesive | 15 |
| pseudotyped | 15 |
| splenocytes | 15 |
| subunit | 15 |
| transmembrane | 15 |
| Medicinal | 15 |
| Section | 15 |
| Xu | 15 |
| Roche | 15 |
| Part | 15 |
| Responses | 15 |
| Methods | 15 |
| NALP3 | 15 |
| NHS | 15 |
| NI | 15 |
| Note | 15 |
| Operation | 15 |
| PCV | 15 |
| PRRS | 15 |
| O157 | 15 |
| Pathogen | 15 |
| Quillaja | 15 |
| Receptor | 15 |
| RG | 15 |
| β4 | 15 |
| Rep | 15 |
| Preventive | 15 |
| Practitioners | 15 |
| Potential | 15 |
| GP5 | 14 |
| DQB1 | 14 |
| Datalink | 14 |
| Diagnostic | 14 |
| Diagnostics | 14 |
| E1 | 14 |
| EEV | 14 |
| Emergence | 14 |
| FDAAA | 14 |
| Future | 14 |
| GLA | 14 |
| Interaction | 14 |
| Goals | 14 |
| Greenberg | 14 |
| Guide | 14 |
| HPIV-3 | 14 |
| HSV-2 | 14 |
| HVR5 | 14 |
| IL-13 | 14 |
| ITP | 14 |
| IX | 14 |
| Inactivated | 14 |
| Current | 14 |
| CyHV-3 | 14 |
| AA | 14 |
| Corbeil | 14 |
| Case | 14 |
| A(H1N1 | 14 |
| KK | 14 |
| ACE-2 | 14 |
| ADCC | 14 |
| AIDSVAX | 14 |
| AIV | 14 |
| ARD | 14 |
| ASCs | 14 |
| Ad5-nCoV | 14 |
| Adaptation | 14 |
| Agro | 14 |
| Annual | 14 |
| Autographa | 14 |
| BD | 14 |
| BPL | 14 |
| Black | 14 |
| CHMP | 14 |
| CTD | 14 |
| CVB1-VLP | 14 |
| Carassius | 14 |
| Cas13 | 14 |
| Johns | 14 |
| Hopkins | 14 |
| Kenya | 14 |
| SNP | 14 |
| Senegal | 14 |
| Singh | 14 |
| Standards | 14 |
| TPR | 14 |
| Turkey | 14 |
| VARV | 14 |
| W | 14 |
| Wales | 14 |
| Wilson | 14 |
| XhoI | 14 |
| YK | 14 |
| cines | 14 |
| hemagglutinin | 14 |
| hydroxychloroquine | 14 |
| marburg | 14 |
| ml | 14 |
| nanogel | 14 |
| perforin | 14 |
| pullulan | 14 |
| route | 14 |
| tabacum | 14 |
| Key | 14 |
| μg | 14 |
| Security | 14 |
| azithromycin | 14 |
| Roy | 14 |
| Oreochromis | 14 |
| Lambert | 14 |
| LC16m8∆ | 14 |
| Rio | 14 |
| Lin | 14 |
| Liposomal | 14 |
| MRSA | 14 |
| Michael | 14 |
| NVX | 14 |
| Nanogel | 14 |
| Norovirus | 14 |
| Mantoux | 14 |
| Palese | 14 |
| Patel | 14 |
| Pfs25 | 14 |
| Plague | 14 |
| Programs | 14 |
| Quality | 14 |
| PER.C6 | 14 |
| Qβ | 14 |
| Recovery | 14 |
| Richard | 14 |
| Girard | 13 |
| Hu | 13 |
| Immunosenescence | 13 |
| IL-21 | 13 |
| IL-1β | 13 |
| IKK | 13 |
| HVT | 13 |
| Host | 13 |
| Hesitancy | 13 |
| H7N3 | 13 |
| H10N8 | 13 |
| Injury | 13 |
| Inhibition | 13 |
| MAP | 13 |
| Institutional | 13 |
| Interferon | 13 |
| Island | 13 |
| Ixodes | 13 |
| Java | 13 |
| Karron | 13 |
| LMIC | 13 |
| Legionella | 13 |
| Level | 13 |
| MAbs | 13 |
| Marketing | 13 |
| Markov | 13 |
| Mediterranean | 13 |
| Full | 13 |
| GDP | 13 |
| Bharat | 13 |
| Formulation | 13 |
| Flavivirus | 13 |
| Modified | 13 |
| AEFI | 13 |
| ANOVA | 13 |
| Adenoviral | 13 |
| Ae | 13 |
| Authority | 13 |
| Britain | 13 |
| CD21 | 13 |
| CELLECTRA | 13 |
| CHO | 13 |
| CPV-2 | 13 |
| CRPV | 13 |
| Caco-2 | 13 |
| Canadian | 13 |
| Caribbean | 13 |
| Co. | 13 |
| CoV2373 | 13 |
| Code | 13 |
| Contextual | 13 |
| Country | 13 |
| DHF | 13 |
| DSS | 13 |
| Dimitrov | 13 |
| ECTV | 13 |
| Elsevier | 13 |
| FHV-1 | 13 |
| FI | 13 |
| Mice | 13 |
| Varroa | 13 |
| Monitoring | 13 |
| Taxonomy | 13 |
| Time | 13 |
| Toxoplasma | 13 |
| Trypanosoma | 13 |
| UKVN | 13 |
| VP28 | 13 |
| Victoria | 13 |
| Wurzer | 13 |
| Yuan | 13 |
| cCHP | 13 |
| cient | 13 |
| den | 13 |
| donovani | 13 |
| fever | 13 |
| henselae | 13 |
| kcal | 13 |
| lymphopenia | 13 |
| mRNAs | 13 |
| nanovaccines | 13 |
| pLD1 | 13 |
| pneumococcus | 13 |
| polyprotein | 13 |
| propiolactone | 13 |
| s. | 13 |
| signifi | 13 |
| swine | 13 |
| vac | 13 |
| Mustela | 13 |
| Tcell | 13 |
| imiquimod | 13 |
| Takeda | 13 |
| RNase | 13 |
| NIS | 13 |
| TLR8 | 13 |
| Nanotechnology | 13 |
| Nasal | 13 |
| Nef | 13 |
| Nicholson | 13 |
| ORT | 13 |
| PB2 | 13 |
| PBMC | 13 |
| PPV | 13 |
| Parainfluenza | 13 |
| PubMed | 13 |
| Origin | 13 |
| Series | 13 |
| Strategic | 13 |
| Related | 13 |
| Resources | 13 |
| Rev | 13 |
| SAR | 13 |
| San | 13 |
| Schultz | 13 |
| Semliki | 13 |
| TACA | 13 |
| Seroprevalence | 13 |
| Standard | 13 |
| RdRp | 13 |
| HAV | 12 |
| HB | 12 |
| Fas | 12 |
| HEV | 12 |
| Hall | 12 |
| 12 | |
| Hilleman | 12 |
| H3N8 | 12 |
| Field | 12 |
| Gam | 12 |
| Gabon | 12 |
| Francisella | 12 |
| Florida | 12 |
| Feldmann | 12 |
| IIb | 12 |
| IFFIm | 12 |
| Kennedy | 12 |
| IOM | 12 |
| Iran | 12 |
| FIPV | 12 |
| Lamphear | 12 |
| LC16 | 12 |
| LBL | 12 |
| Jackson | 12 |
| Islands | 12 |
| IpaB | 12 |
| IP-10 | 12 |
| Int | 12 |
| IgG2b | 12 |
| IgA. | 12 |
| Ia | 12 |
| IVB | 12 |
| ISA | 12 |
| 12 | |
| Asibi | 12 |
| FIM | 12 |
| BamHI | 12 |
| COVID‐19 | 12 |
| COPD | 12 |
| CHP | 12 |
| CD46 | 12 |
| Biol | 12 |
| Bandits | 12 |
| Authorization | 12 |
| CVA | 12 |
| Austria | 12 |
| Animals | 12 |
| Agricultural | 12 |
| AG | 12 |
| AAP | 12 |
| A71 | 12 |
| CPG | 12 |
| CaMV | 12 |
| FCA | 12 |
| Lopinavir | 12 |
| ExPASy | 12 |
| Enterovirus | 12 |
| Eastern | 12 |
| EGFP | 12 |
| E4 | 12 |
| Doytchinova | 12 |
| DTwP | 12 |
| Centres | 12 |
| DRC | 12 |
| DENV-2 | 12 |
| Construction | 12 |
| CoV-2-specific | 12 |
| Chi | 12 |
| Chapter | 12 |
| Larson | 12 |
| Thompson | 12 |
| Lu | 12 |
| Tritrichomonas | 12 |
| cDNA | 12 |
| Walsh | 12 |
| WR | 12 |
| Vaxfectin | 12 |
| V3SWG | 12 |
| Trivalent | 12 |
| Total | 12 |
| chemoprophylaxis | 12 |
| Tables | 12 |
| São | 12 |
| Systemic | 12 |
| Symposium | 12 |
| SNT | 12 |
| SARS‐CoV‐2 | 12 |
| caspase-3 | 12 |
| coryza | 12 |
| SAD | 12 |
| resiquimod | 12 |
| MA | 12 |
| À14 | 12 |
| tularensis | 12 |
| su | 12 |
| rimantadine | 12 |
| rhesus | 12 |
| quintana | 12 |
| dengue-2 | 12 |
| orthopoxvirus | 12 |
| niosomes | 12 |
| mycobacterial | 12 |
| monkeypox | 12 |
| human | 12 |
| health | 12 |
| SAEs | 12 |
| cruzi | 12 |
| S3 | 12 |
| Maryland | 12 |
| NSP4 | 12 |
| NS3 | 12 |
| NOD2 | 12 |
| Multi | 12 |
| Month | 12 |
| Melero | 12 |
| Market | 12 |
| NVCP | 12 |
| Manual | 12 |
| Malta | 12 |
| MS2 | 12 |
| MPs | 12 |
| MCV4 | 12 |
| RotaTeq | 12 |
| NSs | 12 |
| Meta | 12 |
| NYCBH | 12 |
| PRNT | 12 |
| RV144 | 12 |
| Pregnancy | 12 |
| Poliovirus | 12 |
| Pneumonia | 12 |
| Pichia | 12 |
| Paulo | 12 |
| Paramyxoviridae | 12 |
| Peter | 12 |
| PDBsum | 12 |
| PCD180 | 12 |
| PB1 | 12 |
| Overview | 12 |
| Oral | 12 |
| O. | 12 |
| Heat | 11 |
| Greene | 11 |
| HeLa | 11 |
| HPV-16 | 11 |
| HER2 | 11 |
| HEK293 | 11 |
| HCoV-229E | 11 |
| HAI-05 | 11 |
| H5N3 | 11 |
| GCP | 11 |
| GraphPad | 11 |
| Gonzalez | 11 |
| Glycosylation | 11 |
| Genetics | 11 |
| GUS | 11 |
| GM3 | 11 |
| Foot | 11 |
| Humans | 11 |
| Heterologous | 11 |
| ME | 11 |
| IRF-3 | 11 |
| ImmSim | 11 |
| Fernandez | 11 |
| Major | 11 |
| MRC-5 | 11 |
| MDP | 11 |
| M2SR | 11 |
| Lewis | 11 |
| Leroux | 11 |
| Lao | 11 |
| LASV | 11 |
| Kong/213/03 | 11 |
| Karnataka | 11 |
| Jeryl | 11 |
| Invitrogen | 11 |
| Investigational | 11 |
| Industry | 11 |
| Immunother | 11 |
| Immunological | 11 |
| FluSure | 11 |
| Abs | 11 |
| FastVax | 11 |
| Facility | 11 |
| CCL2 | 11 |
| CAM | 11 |
| C57BL/6J | 11 |
| Burkholderia | 11 |
| BepiPred | 11 |
| Bengal | 11 |
| BTV-2 | 11 |
| BALT | 11 |
| Arab | 11 |
| Antiviral | 11 |
| Albert | 11 |
| Adjuvanted | 11 |
| MenB | 11 |
| APHIS | 11 |
| ANTIGENpro | 11 |
| AEs | 11 |
| ACKTR | 11 |
| CF | 11 |
| COV-2 | 11 |
| CVD | 11 |
| ERRAT | 11 |
| FLU | 11 |
| FBS | 11 |
| F4 | 11 |
| Encephalitis | 11 |
| Emirates | 11 |
| El | 11 |
| Education | 11 |
| ED | 11 |
| Chanock | 11 |
| Drosophila | 11 |
| Dr | 11 |
| Daniell | 11 |
| DOTAP | 11 |
| Cov | 11 |
| Complex | 11 |
| Co | 11 |
| MenA | 11 |
| JC | 11 |
| Monoclonal | 11 |
| Webby | 11 |
| bacille | 11 |
| b. | 11 |
| airways | 11 |
| Zoster | 11 |
| Yamagata | 11 |
| Wood | 11 |
| Weniger | 11 |
| Wellcome | 11 |
| VacSIM | 11 |
| St. | 11 |
| VE | 11 |
| Unit | 11 |
| Ulmer | 11 |
| USSR | 11 |
| ToxinPred | 11 |
| Support | 11 |
| Sun | 11 |
| Stomatitis | 11 |
| californica | 11 |
| d. | 11 |
| ective | 11 |
| gene | 11 |
| × | 11 |
| Moraxella | 11 |
| tein | 11 |
| suffi | 11 |
| rotaviruses | 11 |
| rhabdovirus | 11 |
| profi | 11 |
| plasmid | 11 |
| p.i | 11 |
| newcastle | 11 |
| nasal | 11 |
| multiepitope | 11 |
| microplus | 11 |
| mer | 11 |
| mannan | 11 |
| identifi | 11 |
| herpesviruses | 11 |
| Step | 11 |
| el | 11 |
| Spring | 11 |
| Prime | 11 |
| Poxvirus | 11 |
| Potency | 11 |
| Polynesia | 11 |
| Pol | 11 |
| Picornaviridae | 11 |
| Philadelphia | 11 |
| Papillomavirus | 11 |
| PSIPRED | 11 |
| PSII | 11 |
| PD-1 | 11 |
| Orthomyxoviridae | 11 |
| Number | 11 |
| NVAC | 11 |
| NPC1 | 11 |
| Solidarity | 11 |
| Myanmar | 11 |
| NGOs | 11 |
| Prevent | 11 |
| Papania | 11 |
| ProtParam | 11 |
| Rg | 11 |
| SnapGene | 11 |
| Shingrix | 11 |
| Shaw | 11 |
| Sharma | 11 |
| Selection | 11 |
| Schijns | 11 |
| Rotaviruses | 11 |
| Roels | 11 |
| Rybicki | 11 |
| Recent | 11 |
| Rescue | 11 |
| Puppies | 11 |
| Ref | 11 |
| Recognition | 11 |
| Qiagen | 11 |
| Respir | 11 |
| Ikeda | 10 |
| HRP | 10 |
| HTN | 10 |
| HVTN | 10 |
| IC50 | 10 |
| Harvard | 10 |
| IL | 10 |
| IgG. | 10 |
| Iowa | 10 |
| H5N2 | 10 |
| HAART | 10 |
| Gill | 10 |
| H1N1pdm09 | 10 |
| Gulf | 10 |
| Greece | 10 |
| Glycoprotein | 10 |
| Glybera | 10 |
| GM2 | 10 |
| Genomic | 10 |
| García | 10 |
| JetH | 10 |
| GS | 10 |
| Janeiro | 10 |
| MUC1 | 10 |
| Jiang | 10 |
| Jun | 10 |
| GANJV | 10 |
| McElhaney | 10 |
| Mayinga | 10 |
| Mannheimia | 10 |
| Malawi | 10 |
| Maassab | 10 |
| MSP | 10 |
| MPER | 10 |
| MOMP | 10 |
| ML | 10 |
| MEDI-493 | 10 |
| MALP-2 | 10 |
| MAC | 10 |
| Los | 10 |
| Long | 10 |
| Lkt50 | 10 |
| Levine | 10 |
| Left | 10 |
| Lactococcus | 10 |
| LRT | 10 |
| Kittens | 10 |
| GDT | 10 |
| Aeromonas | 10 |
| Frequency | 10 |
| Boophilus | 10 |
| Bernard | 10 |
| Benjamin | 10 |
| Babiuk | 10 |
| BMGF | 10 |
| Australian | 10 |
| Aug | 10 |
| Atlantic | 10 |
| AntiJen | 10 |
| Andrew | 10 |
| Alphavirus | 10 |
| Agenda | 10 |
| Affairs | 10 |
| Acad | 10 |
| AZD1222 | 10 |
| ACT | 10 |
| AAFP | 10 |
| A11:01 | 10 |
| A(H7N9 | 10 |
| 3C | 10 |
| 17D | 10 |
| Messenger | 10 |
| Biography | 10 |
| Brewer | 10 |
| ElliPro | 10 |
| C3 | 10 |
| Ehrlich | 10 |
| ESO-1 | 10 |
| EMEA | 10 |
| Dynamics | 10 |
| Dodge | 10 |
| DMSO | 10 |
| Cytokines | 10 |
| Cutter | 10 |
| Cryo | 10 |
| Crowe | 10 |
| Corynebacterium | 10 |
| Contribution | 10 |
| Clover | 10 |
| Chu | 10 |
| Chlamydophila | 10 |
| Chemical | 10 |
| Characteristics | 10 |
| CanSino | 10 |
| Cambodia | 10 |
| CD11c | 10 |
| CAV-2 | 10 |
| MedImmune | 10 |
| VP40 | 10 |
| Monovalent | 10 |
| defensin | 10 |
| crLyme | 10 |
| control | 10 |
| chicken | 10 |
| catarrhalis | 10 |
| Zhu | 10 |
| Yap | 10 |
| Yak | 10 |
| Wolbachia | 10 |
| Wisconsin | 10 |
| Walter | 10 |
| WCL | 10 |
| Venezuela | 10 |
| Varicella | 10 |
| VRC | 10 |
| VACCINES | 10 |
| Uptake | 10 |
| Tween | 10 |
| Trump | 10 |
| Tris | 10 |
| Tregoning | 10 |
| Toronto | 10 |
| cynomolgus | 10 |
| des | 10 |
| Targeting | 10 |
| dpi | 10 |
| Monto | 10 |
| ␣ | 10 |
| −20 | 10 |
| Ò | 10 |
| west | 10 |
| virosome | 10 |
| un | 10 |
| turkey | 10 |
| tocilizumab | 10 |
| st | 10 |
| psittaci | 10 |
| palivizumab | 10 |
| multiepitopic | 10 |
| mice | 10 |
| malaria | 10 |
| kinase | 10 |
| infantum | 10 |
| gp140 | 10 |
| genome | 10 |
| gene(s | 10 |
| fowlpox | 10 |
| Therapeutics | 10 |
| fibrosarcomas | 10 |
| TLR-9 | 10 |
| Pertussis | 10 |
| Peiris | 10 |
| Palampur | 10 |
| PV | 10 |
| PRSV | 10 |
| PR/8/34 | 10 |
| PDR | 10 |
| PAMP | 10 |
| P.L. | 10 |
| OspC | 10 |
| Orf | 10 |
| OAS | 10 |
| News | 10 |
| Neospora | 10 |
| Natl | 10 |
| Nadu | 10 |
| Na | 10 |
| NJ | 10 |
| Mosquirix | 10 |
| Moscow | 10 |
| Sutter | 10 |
| Mortality | 10 |
| Perrie | 10 |
| ORF2 | 10 |
| Phyre | 10 |
| S1-E2 | 10 |
| Standardization | 10 |
| Spodoptera | 10 |
| Placebo | 10 |
| Shi | 10 |
| Shanghai | 10 |
| Schwarz | 10 |
| Saint | 10 |
| SYFPEITHI | 10 |
| STD | 10 |
| SCCS | 10 |
| Saccharomyces | 10 |
| RotaShield | 10 |
| Rhesus | 10 |
| Regulation | 10 |
| Register | 10 |
| Reddy | 10 |
| RFI-641 | 10 |
| Pune | 10 |
| Rotavac | 10 |
| President | 10 |
| Pneumococcal | 10 |
| HC | 9 |
| GRAVY | 9 |
| Flury | 9 |
| Formalin | 9 |
| HCoVs | 9 |
| GBNV | 9 |
| Guo | 9 |
| Galaxy | 9 |
| GeoSentinel | 9 |
| Grant | 9 |
| H7N1 | 9 |
| Fast | 9 |
| Figs | 9 |
| EpiVax | 9 |
| FasL | 9 |
| FL | 9 |
| FASTA | 9 |
| F2 | 9 |
| F1 | 9 |
| Experimental | 9 |
| Exp | 9 |
| Evolution | 9 |
| Equine | 9 |
| English | 9 |
| Engagement | 9 |
| Handbook | 9 |
| Ellis | 9 |
| HTI | 9 |
| Licensure | 9 |
| Hasan | 9 |
| HbsAg | 9 |
| Dwivedi | 9 |
| Lys | 9 |
| Ludwig | 9 |
| Low | 9 |
| Linear | 9 |
| Langridge | 9 |
| Koprowski | 9 |
| Kinnear | 9 |
| Kahn | 9 |
| Jatropha | 9 |
| Intracellular | 9 |
| Inspection | 9 |
| Injection | 9 |
| Ingelheim | 9 |
| Infl | 9 |
| Indonesia/05/2005 | 9 |
| Immunomodulatory | 9 |
| Immunizations | 9 |
| IkappaB | 9 |
| IgG2c | 9 |
| ISCOMs | 9 |
| IIc | 9 |
| IFNc | 9 |
| Hubei | 9 |
| Heterosubtypic | 9 |
| ESAT-6 | 9 |
| Agents | 9 |
| Duncan | 9 |
| Angeles | 9 |
| CEV | 9 |
| CD19 | 9 |
| CD14 | 9 |
| Boehringer | 9 |
| Berna | 9 |
| BHK-21 | 9 |
| Autoimmune | 9 |
| AuNPs | 9 |
| Assay | 9 |
| Arbidol | 9 |
| Anthrax | 9 |
| Anthony | 9 |
| Anderson | 9 |
| Duck | 9 |
| Andersen | 9 |
| Aldrich | 9 |
| Agrobacterium | 9 |
| Acinetobacter | 9 |
| Accession | 9 |
| ATCC | 9 |
| APS | 9 |
| ANCA | 9 |
| ACC | 9 |
| A(H3N2 | 9 |
| 3Drefine | 9 |
| MO | 9 |
| CHIM | 9 |
| CPMV | 9 |
| CPV2b | 9 |
| Candida | 9 |
| DsMV | 9 |
| Dow | 9 |
| Doses | 9 |
| Disulfide | 9 |
| Dendrimer | 9 |
| Darby | 9 |
| DTH | 9 |
| DOPE | 9 |
| DM | 9 |
| DCM | 9 |
| CureVac | 9 |
| Cui | 9 |
| Copenhagen | 9 |
| Cooperation | 9 |
| Common | 9 |
| Combination | 9 |
| Colorado | 9 |
| Chiron | 9 |
| Child | 9 |
| Chagas | 9 |
| ChAd3 | 9 |
| Cardenas | 9 |
| Carbohydrate | 9 |
| Cape | 9 |
| Candidates | 9 |
| MMF | 9 |
| Biosciences | 9 |
| MPS | 9 |
| antirabies | 9 |
| gondii | 9 |
| gill | 9 |
| fd | 9 |
| f1 | 9 |
| datasheet | 9 |
| c. | 9 |
| burnetii | 9 |
| bilosomes | 9 |
| berghei | 9 |
| b978 | 9 |
| arthralgia | 9 |
| apolar | 9 |
| ankara | 9 |
| heterosubtypic | 9 |
| acid | 9 |
| Wolff | 9 |
| Winter | 9 |
| Wen | 9 |
| Weekly | 9 |
| Walker | 9 |
| Waldeyer | 9 |
| Vietnam/1203/2004 | 9 |
| Vical | 9 |
| VN/1203/04 | 9 |
| VII | 9 |
| UIV | 9 |
| gp3 | 9 |
| immunogens | 9 |
| Therapeutic | 9 |
| oligodeoxynucleotide | 9 |
| MR | 9 |
| velogenic | 9 |
| vaccinees | 9 |
| tb | 9 |
| siRNAs | 9 |
| sc | 9 |
| rHVT | 9 |
| protein(s | 9 |
| protamine | 9 |
| pro | 9 |
| pasteur | 9 |
| pI | 9 |
| neuraminidase | 9 |
| lipid | 9 |
| neo | 9 |
| ned | 9 |
| ne | 9 |
| nCoV-19 | 9 |
| muramyl | 9 |
| mol | 9 |
| mid | 9 |
| meningoencephalitis | 9 |
| zika | 9 |
| melitensis | 9 |
| lopinavir | 9 |
| lipoplexes | 9 |
| Treanor | 9 |
| merozoite | 9 |
| Team | 9 |
| Mountain | 9 |
| Open | 9 |
| Oncorhynchus | 9 |
| Oct | 9 |
| ORF1a | 9 |
| Ni | 9 |
| Nguyen | 9 |
| Nanovaccines | 9 |
| Nano-11 | 9 |
| NTO | 9 |
| Multivalent | 9 |
| Multiple | 9 |
| Ms03 | 9 |
| Morbidity | 9 |
| PB1-F2 | 9 |
| Molina | 9 |
| Models | 9 |
| Millennium | 9 |
| Memory | 9 |
| Medicare | 9 |
| Manufacturers | 9 |
| Man | 9 |
| Madin | 9 |
| Madagascar | 9 |
| Macaca | 9 |
| MW | 9 |
| Target | 9 |
| Oregon | 9 |
| Mol | 9 |
| PD | 9 |
| RI | 9 |
| Tamil | 9 |
| PHK | 9 |
| TILs | 9 |
| TI-2 | 9 |
| Sentinel | 9 |
| Seattle | 9 |
| SIR | 9 |
| Rubella | 9 |
| Roberts | 9 |
| Rino | 9 |
| Rickettsia | 9 |